Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Pishvaian MJ, Blais EM, Brody JR, Lyons E, DeArbeloa P, Hendifar A, Mikhail S, Chung V, Sahai V, Sohal DPS, Bellakbira S, Thach D, Rahib L, Madhavan S, Matrisian LM, Petricoin EF 3rd. Pishvaian MJ, et al. Lancet Oncol. 2020 Apr;21(4):508-518. doi: 10.1016/S1470-2045(20)30074-7. Epub 2020 Mar 2. Lancet Oncol. 2020. PMID: 32135080 Free PMC article.
Postresection chemotherapy for pancreatic cancer.
Smaglo BG, Pishvaian MJ. Smaglo BG, et al. Among authors: pishvaian mj. Cancer J. 2012 Nov-Dec;18(6):614-23. doi: 10.1097/PPO.0b013e31827459d8. Cancer J. 2012. PMID: 23187850 Review.
Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Gurka MK, et al. Among authors: pishvaian mj. Radiat Oncol. 2013 Mar 1;8:44. doi: 10.1186/1748-717X-8-44. Radiat Oncol. 2013. PMID: 23452509 Free PMC article. Clinical Trial.
PARP inhibitors for chemoprevention--letter.
Chand SN, Blanco FF, Jimbo M, Tsangaris TN, Cristofanilli M, Yeo CJ, Winter JM, Pishvaian MJ, Brody JR. Chand SN, et al. Among authors: pishvaian mj. Cancer Prev Res (Phila). 2014 Nov;7(11):1170-1. doi: 10.1158/1940-6207.CAPR-14-0220. Cancer Prev Res (Phila). 2014. PMID: 25368011 No abstract available.
Upgrading gemcitabine with recycled kinase inhibitors.
Blanco FF, Pishvaian MJ, Brody JR. Blanco FF, et al. Among authors: pishvaian mj. Cell Cycle. 2014;13(18):2810-1. doi: 10.4161/15384101.2014.954211. Cell Cycle. 2014. PMID: 25486467 Free PMC article. No abstract available.
Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer.
Brody JR, Yabar CS, Zarei M, Bender J, Matrisian LM, Rahib L, Heartwell C, Mason K, Yeo CJ, Peiper SC, Jiang W, Varieur K, Madhavan S, Petricoin E 3rd, Fortuna D, Curtis M, Wang ZX, Pishvaian MJ, Winter JM. Brody JR, et al. Among authors: pishvaian mj. Cancer Biol Ther. 2018 Apr 3;19(4):249-253. doi: 10.1080/15384047.2016.1210743. Epub 2018 Mar 6. Cancer Biol Ther. 2018. PMID: 27466707 Free PMC article.
106 results